Bausch Health Companies Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Bausch Health Companies Inc. on August 14, 2025. The report details the termination of a material definitive agreement and the subsequent departure of two directors from the Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and contractual changes rather than financial performance.
Material Changes
- Termination of Agreement: The Director Appointment and Nomination Agreement dated February 23, 2021, and a supplemental Letter Agreement dated May 20, 2025, between the Company and the Icahn Group terminated effective August 14, 2025.
- Reason for Termination: The termination occurred because the Icahn Group's net long position in the Company's shares fell below the required threshold stipulated in the Appointment and Nomination Agreement.
- Board Departures: Brett M. Icahn and Steven D. Miller resigned from the Board of Directors on August 14, 2025, in connection with the agreement termination. Both had served since March 17, 2021, with Mr. Miller also serving on the Audit and Risk Committee.
Outlook, Risks, and Management Commentary
Management stated that the resignations of Messrs. Icahn and Miller did not result from any disagreement with the Company. A press release regarding these matters was issued on August 15, 2025, and is furnished as Exhibit 99.1. The filing does not contain specific forward-looking guidance, risk factors, or contingencies beyond the immediate governance changes.
Key Facts for Investor Verification
- Verify the current shareholding percentage of the Icahn Group to confirm it remains below the threshold required for board representation.
- Review the Company's proxy statement or subsequent filings to determine if new directors have been appointed to replace the resigned members.
- Confirm the composition of the Audit and Risk Committee following Mr. Miller's resignation to ensure quorum and compliance.
- Monitor for any future filings regarding the relationship between the Company and the Icahn Group.